Hofseth BioCare earnings sink further into red

The company is concerned about its ability to sell products at sufficiently high prices going forward.

Jon Olav Ødegård, CFO Hofseth BioCare — Jon Olav Ødegård, CFO Hofseth BioCarePhoto: Anders Furuset

Demi Korban

Published 20 March 2020, 10:47Updated 4 June 2020, 15:57

Hofseth Biocare Roger Hofseth biotech Atlantic Sapphire Mergers & Acquisitions